logo
A Hiker Was Missing for Nearly a Year—Until an AI System Recognized His Helmet

A Hiker Was Missing for Nearly a Year—Until an AI System Recognized His Helmet

WIREDa day ago
Aug 4, 2025 5:30 AM Using AI to analyze thousands of frames taken by drone, a mountain rescue team has found the body of a doctor who had been missing since September 2024. Drone on Monviso locating the body of a missing hiker. Photo: CNSAS
How long does it take to identify the helmet of a hiker lost in a 183-hectare mountain area, analyzing 2,600 frames taken by a drone from approximately 50 meters away? If done with a human eye, weeks or months. If analyzed by an artificial intelligence system, one afternoon. The National Alpine and Speleological Rescue Corps, known by it's Italian initialism CNSAS, relied on AI to find the body of a person missing in Italy's Piedmont region on the north face of Monviso—the highest peak in the Cottian Alps—since September 2024.
According to Saverio Isola, the CNSAS drone pilot who intervened along with his colleague Giorgio Viana, the operation—including searching for any sign of the missing hiker, the discovery and recovery of his body, and a stoppage due to bad weather—lasted less than three days. The Recovery Operations
With his back to the ground, his gaze fixed on the mountains, 600 meters below the summit, the body of 64-year-old Ligurian doctor Nicola Ivaldo was found on the morning of Thursday, July 31, more than 10 months after his disappearance, thanks to his helmet that clashed with the rest of the landscape.
"It was the AI software that identified some pixels of a different color in the images taken on Tuesday," explains Isola, reconstructing step-by-step the operation that led to the discovery and recovery of the remains located at an altitude of approximately 3,150 meters, in the rightmost of the three ravines that cut through the north face of Monviso, above a hanging glacier.
The team collected all the images in five hours with just two drones on the morning of Tuesday, July 29, and analyzed them using AI software during the afternoon of the same day. By that evening, the rescuers already had a series of "suspicious spots" to check. Only fog and bad weather the following day delayed the operations.
"We woke up at 4 am to reach a very distant point with good visibility on the channel where the red pixels had been detected, and we used the drone to see if it was indeed the helmet," says Isola. "Then we took all the necessary photos and measurements, sending the information to the rescue coordination center, which was then able to dispatch the Fire Brigade helicopter for the recovery and police operations." The Role of AI
Every drone operation is part of a rigorous method developed by CNSAS in coordination with ENAC, the national agency that oversees civil aviation. "We've been using drones for about five years, and for about a year and a half we've been integrating color and shape recognition technologies, developing them month by month," Isola explains. "But all of this would be useless without the teams of technicians."
Information from Ivaldo's cell phone was immediately invaluable. The two drone pilots who navigated the area were aided by the experience and knowledge of four expert mountain rescuers. "It's a human achievement, but without technology, it would have been an impossible mission. It's a team success," said Isola.
Isola, his colleague Viana, and the few other "select pilots" from the CNSAS know well how crucial technology can be if used properly. "Even in the recovery operations following the Marmolada Glacier tragedy, it allowed us to operate in inaccessible areas and recover all the necessary artifacts," Isola recalls. "It prevented the rescuers from risking their lives."
The CNSAS goal is further collaboration between artificial intelligence and drones to prevent the most serious consequences of mountain accidents and save missing people while they are still alive. This combination can also be used to obtain and analyze information with thermal imaging cameras, which are sensitive only to living beings.
"Just like with still images, AI is also able to interpret thermal data and provide valuable information in just a few hours," Isola explains. "In Sardinia, a colleague recently rescued some climbers whose ropes were stuck on a rock face and was able to locate them only thanks to the drone and other technologies that are part of our method. Many of them are from wartime; we have recovered and converted them."
The hope is that, with ever-increasing use, the number of fatal mountain accidents can be drastically reduced.
This story originally appeared on WIRED Italy and has been translated from Italian.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tensive appoints medical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market
Tensive appoints medical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market

Yahoo

time2 hours ago

  • Yahoo

Tensive appoints medical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market

Has more than 30 years of experience bringing innovations to market, including one of the world's first drug-eluting coronary stents at Angiotech Pharma Appointment adds world-class capabilities to Tensive as the company approaches pivotal clinical trial milestones Pivotal trial may enable European and U.S. commercialization of Tensive's innovative bioresorbable REGENERA™ and SOFTAG™ devices for breast reconstruction and tissue marking Tensive published positive first impressions from pivotal trial in April, and from first-in-human trial in 2023 Milan, Italy – August 5, 2025 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company, and the developer of REGENERA™ and SOFTAG™ bioresorbable scaffolds for breast reconstruction and tissue marking, has appointed Bill Hunter, MD, as Chairman of its Board of Directors. Dr. Hunter brings more than 30 years of leadership in the medical technology and life sciences sectors. His appointment reflects Tensive's focus on strengthening its governance and expanding its global network as it accelerates toward pivotal clinical milestones and commercialization in the U.S. and Europe. Dr. Hunter is the founder and CEO of Canary Medical, a medical data company developing implantable sensor technology. Previously, he founded Angiotech Pharmaceuticals, where he led the development of one of the world's first drug-eluting coronary stents, a multi-billion-dollar innovation that transformed interventional cardiology. 'It's a great honor and validation of the medical potential of Tensive's advanced biomaterials that Bill has accepted to lead our board of directors. His track record of successfully guiding pioneering technologies from concept to commercialization is unmatched,' said Sanjay Kakkar, Chief Executive Officer of Tensive. 'Bill's strategic insights and industry perspectives will be crucial advantages as we complete registrational studies and advance our first device into regulatory processes for marketing approval and commercialization in the U.S. and Europe.' Tensive's innovative polymeric bioresorbable scaffolds allow a natural, non-invasive, permanent and safe solution for breast reconstruction during lumpectomy. In addition, they enable precision tissue marking, demarcating the affected area to direct more targeted radiotherapy and improve imaging accuracy during surveillance and follow-up. 'I am truly excited to join Tensive at such a pivotal moment in its journey,' said Bill Hunter, MD, Chairman of the Tensive Board of Directors. 'In addition to being impressed by the leadership, I became convinced that this was an exceptional opportunity after reviewing the recently published interim data from the ongoing pivotal study of REGENERA™, as well as the excellent long-term follow-up data from the first-in-human clinical trial. The enthusiasm expressed by the key opinion leaders involved with the clinical studies further confirmed my impression of the data. I look forward to supporting Sanjay and his experienced team at Tensive as they bring REGENERA™ and SOFTAG™ to the market.' REGENERA™ / SOFTAG™ advanced biomaterial is a bioresorbable implant designed to be placed during lumpectomy surgery. The bioresorbable medical device is gradually absorbed by the body and enables the patient's own tissue to regrow in the area it fills. The result is breast restoration composed of natural tissue that preserves the patient's original breast shape and feel, yet is clearly differentiated from surrounding tissues on imaging, supporting more targeted delivery of radiotherapy and more accurate monitoring for potential recurrence. The biomaterial used in REGENERA™ and SOFTAG™ resembles a sponge with a fine scaffold matrix; its placement during the lumpectomy surgery is a one-step, minimally invasive, rapid and easy-to-adopt procedure. Currently, patients undergoing benign and malignant lumpectomy do not typically receive cosmetic intervention to prevent breast disfigurement, which can be psychologically devastating. Of the 2.1 million lumpectomies performed worldwide each year, 1.9 million are not reconstructed, constituting a sizeable unmet clinical need [1]. Despite the psychological impact of breast disfigurement following lumpectomy, more common cosmetic surgery options are rarely used, because they entail invasive and complex procedures that often fail to achieve the desired outcome. Preliminary data from the first 16 patients in Tensive's ongoing multi-center pivotal trial in 94 patients undergoing malignant lumpectomy were published in Updates in Surgery in April 2025, with investigators writing: 'In conclusion, we are convinced that REGENERA™ could represent a great innovation in breast oncological surgery, representing a possible alternative to volume replacement with faster operative time, faster recovery, less morbidity, and good patient satisfaction [2].' These results followed the publication in Breast Cancer in 2023 of six-month follow-up data from five patients in a first-in-human trial that demonstrated positive outcomes in terms of both safety and performance, leading the clinical investigators who authored the paper to conclude that the data were 'paving the way to an innovative approach with a potential remarkable impact on clinical application of tissue engineering [3].' [1] Analysis based on estimates from the International Society of Aesthetic Plastic Surgery (ISAPS), Breast Cancer Research Foundation (BCRF), the American College of Surgeons (ACS), the World Health Organization (WHO) and Global Market Insights.[2] A.V.E. Lisa et al. Updates in Surgery Apr 2025. Mariniello et al. Breast Cancer 2023. S.r.l. ( is a clinical-stage advanced biomaterials medical device company developing bioresorbable polymeric scaffolds for breast reconstruction and tissue marking. Its patented REGENERA™ biomimetic scaffold is designed to allow regeneration of a patient's own breast tissue to create natural, safe, and lasting reconstruction for patients recovering from lumpectomy or undergoing cosmetic procedures, while its SOFTAG™ precision tissue marking device enables more targeted delivery of radiotherapy and increases the accuracy of surveillance and follow-up. Tensive's mission is to improve clinical outcomes and the quality of life for women worldwide through accessible, innovative, and sustainable solutions. For more information please contact: Tensive Srl Cohesion Bureau media@ Italian and international media & investorsGiovanni Ca' Zorzitensive@ 7 8467 0727 Attachment 20250805 Tensive PR Bill Hunter appointment (final)Error in retrieving data Sign in to access your portfolio Error in retrieving data

METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing's Biopharmaceutical Innovation Engine
METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing's Biopharmaceutical Innovation Engine

Yahoo

time9 hours ago

  • Yahoo

METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing's Biopharmaceutical Innovation Engine

BEIJING, China, Aug. 4, 2025 /PRNewswire/ -- METiS Technologies, a global leader in AI-driven nanodelivery innovation, today announced the successful completion of its RMB 400 million Series D financing round. The announcement was made at the Zhongguancun (Daxing) Cell and Gene Therapy Industrial Park, a key hub for Beijing's life sciences sector. Financing Co-led by Beijing Medical and Health Industry Investment Fund and Daxing Industrial Investment Fund The Series D round was co-led by the Beijing Medical and Health Industry Investment Fund and the Daxing Industrial Investment Fund. The new capital will be used to accelerate METiS' core strategic initiatives, including automation upgrades to its proprietary platform, in-house pipeline development, expansion of global partnerships, and recruitment of world-class talent. Left: Dr. Chris LAI, Co-founder and CEO of METiS Technologies; Right: Mr. REN Peng, Chairman and General Manager, Shunxi Management Co., Ltd., a General Partner of the Beijing Medical and Health Industry Investment Fund The Beijing Medical and Health Industry Investment Fund (Limited Partnership) is one of eight major industrial funds established with support from the Beijing Municipal Government. It focuses on innovative pharmaceuticals, advanced medical devices, and emerging technologies such as cell and gene therapy (CGT) and digital health. The fund plays a key role in accelerating the city's biotech innovation ecosystem. Mr. REN Peng, Chairman and General Manager of Shunxi Management Co.,Ltd. commented: "Healthcare is a cornerstone of Beijing's innovation-driven strategy and a vital engine of emerging productivity. With the launch of the city's AI+Healthcare Innovation Action Plan, Beijing is strategically integrating AI with life sciences to lead the next phase of high-quality growth. Our RMB 20 billion fund reflects our commitment to advancing innovation in CGT. METiS fills a critical gap in advanced formulation and delivery systems, and we believe their technology will set new standards in AI-powered nanodelivery." Mr. LI Ming, Chairman of Beijing Daxing District Investment Group Co., Ltd., added: "Daxing District is committed to making biopharma a core pillar of its economic growth strategy. The launch of the OpenCGT platform marks a major milestone that will accelerate the commercialization of cutting-edge technologies, while attracting top global talent, capital, and innovation to Daxing - enhancing our competitiveness in CGT on the world stage." Mr. HUANG Hantao, Deputy General Manager of CICC Capital, noted: "We are grateful for the strong support from Beijing's leadership, Shunxi Management, and Daxing District across policy, capital, talent, and infrastructure. METiS has made tremendous progress over the past two years. As a long-term investor, CICC Capital will continue to support the company in R&D collaborations with our portfolio companies, clinical development, talent acquisition, and capital markets—empowering the next wave of breakthroughs in AI-enabled drug delivery."

SIGGRAPH 2025 Announces Keynote Presentations Featuring Top Technological Marvels Shaping Our Trajectory Toward a Better Future
SIGGRAPH 2025 Announces Keynote Presentations Featuring Top Technological Marvels Shaping Our Trajectory Toward a Better Future

Yahoo

time9 hours ago

  • Yahoo

SIGGRAPH 2025 Announces Keynote Presentations Featuring Top Technological Marvels Shaping Our Trajectory Toward a Better Future

Topics Ranging From AI Algorithms to the Search for Life in the Universe Take Center Stage With Speakers From Adobe Research, Autodesk, NVIDIA, and More. VANCOUVER, BC, Aug. 4, 2025 /PRNewswire/ -- SIGGRAPH 2025, the world's premier conference on computer graphics and interactive techniques, is returning to center stage this year on Sunday, 10 August through Thursday, 14 August 2025 at the Vancouver Convention Centre. This year's conference features an extraordinary lineup of keynote speakers from Adobe Research, Autodesk, NVIDIA, and more, as they address trending topics ranging from artificial intelligence (AI) and generative art to the search for life beyond Earth. This year's Keynote Presentations bring together the most innovative minds across science, technology, and design. The ultimate goal of the keynote lineup is to share bold ideas, ignite inspiration, and stimulate critical thinking of attendees. "Each year, the SIGGRAPH keynote stage becomes a window into the future, not just of computer graphics and interactive techniques, but of how these fields shape our world," SIGGRAPH 2025 Conference Chair Ginger Alford said. "From exploring the creative boundaries of AI to visualizing alien worlds, our 2025 Keynote Presentations exemplify the visionary spirit that defines this community. Their work challenges us to think differently, collaborate boldly, and expand the way we tell stories, solve problems, and imagine what's possible." This year's Keynote Presentations include: Can Computers Create Art?SIGGRAPH 2025 Keynote: Dr. Aaron HertzmannMonday, 11 August 20259 am PDT Dr. Aaron Hertzmann is a principal scientist at Adobe Research and affiliate faculty at the University of Washington. He has published over 125 papers in computer graphics, AI, and art. He is an ACM Fellow, an IEEE Fellow, and a winner of the 2024 ACM SIGGRAPH Computer Graphics Achievement Award. He will discuss how the developments of new neural network algorithms for making art parallel the development of previous artistic technologies, like oil paint, photography, and traditional computer graphics. He argues that art is a social phenomenon and that AI algorithms will not be considered artists in the foreseeable future. However, they will change the way we make and understand art, for better and for worse. SIGGRAPH 2025 | NVIDIA Research Special AddressPresented by: Sanja Fidler, Aaron Lefohn, and Ming-Yu LiuMonday, 11 August 20254 pm PDT Sanja Fidler, Aaron Lefohn, and Ming-Yu Liu are NVIDIA Research Vice Presidents who imagine and chart the next frontier of graphics and simulation. Together, they will showcase the latest breakthroughs in computer graphics technologies, from neural rendering and materials to world foundation models essential for advancing physical AI. They will explore new opportunities and applications these capabilities are unlocking across media, automotive, manufacturing, and robotics. Sanja Fidler, vice president of AI research, has co-authored over 130 scientific papers across the fields of computer vision, machine learning, and NLP. Aaron Lefohn, vice president of graphics research, oversees teams focused on real-time rendering, AI graphics, and graphics systems. Aaron has led real-time rendering and graphics programming model research breakthroughs featured at SIGGRAPH for over 15 years. Ming-Yu Liu is a vice president of research at NVIDIA and an IEEE fellow. He leads the Deep Imagination Research lab, which currently focuses on generative AI for physical AI. His research team has helped create several new product categories for NVIDIA. Future Earth: Storytelling From Space and the Exoplanet RevolutionSIGGRAPH 2025 Keynote: Dr. Anjali TripathiTuesday, 12 August 20259 am PDT Dr. Anjali Tripathi is an astrophysicist and NASA's inaugural Exoplanet Science Ambassador. An expert in planet formation and evolution, she has contributed to the design of new space missions at NASA's Jet Propulsion Laboratory (JPL). As a leading science communicator, she is regularly featured by the BBC, PBS, and TED and serves as a film and television consultant for the National Academy of Sciences. She previously led science policy for the White House Office of Science and Technology Policy and the U.S. Department of Agriculture. In an awe-inspiring keynote about the evolving fields of exoplanets and space exploration, she will provide a behind-the-scenes look at the future of the search for life in the Universe and how it's reshaping the art and storytelling of Earth and alien worlds. Sponsored Keynote by Autodesk: Exploring AI in the Future of Storytelling With David S. GoyerPresented by: David S. Goyer, Tye Sheridan, Nikola Todorovic, Carolyn Giardina, Mike Haley, and Maurice PatelTuesday, 12 August 20252 pm PDT Autodesk presents a dynamic keynote exploring how AI is reshaping storytelling across film, TV, and games. Acclaimed writer, director, and producer David S. Goyer ("The Dark Knight" trilogy, "Foundation", "The Sandman") will reflect on the role of technology in his work and the impact AI will have on future creators. He'll be joined by actor Tye Sheridan and filmmaker Nikola Todorovic, co-founders of Wonder Dynamics (now part of Autodesk), to discuss how AI is reshaping the creative process, expanding access, and redefining the future of storytelling in a discussion moderated by award-winning journalist and author Carolyn Giardina. The keynote will also feature Autodesk leaders Mike Haley and Maurice Patel sharing how Autodesk's legacy of research and cross-industry innovation is driving the development of practical, creator-first AI tools like MotionMaker in Maya and Autodesk Flow Studio. This year's keynote lineup reflects SIGGRAPH's commitment to advancing innovation, creativity, and collaboration across disciplines. Find more information about SIGGRAPH 2025, including this year's keynote speakers, at About ACM, ACM SIGGRAPH, and SIGGRAPH 2025The Association for Computing Machinery (ACM) is the world's largest educational and scientific computing society, uniting educators, researchers, and professionals to inspire dialogue, share resources, and address the field's challenges. SIGGRAPH is a special interest group within ACM that serves as an interdisciplinary community for members in research, technology, and applications in computer graphics and interactive techniques. The SIGGRAPH conference is the world's leading annual interdisciplinary educational experience showcasing the latest in computer graphics and interactive techniques. SIGGRAPH 2025, the 52nd annual conference hosted by ACM SIGGRAPH, will take place live 10–14 August at the Vancouver Convention Centre, along with a Virtual Access option. View original content to download multimedia: SOURCE SIGGRAPH 2025

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store